Lotus Healthcare Group is a newly formed enterprise that will own, develop and operate patient-centered healthcare clinics to provide opioid dependent patients with a higher level of comprehensive care than other available options currently offered. LHG will provide a “whole patient” approach to treat substance use disorders by combining a Patient-Centered Medical Home (“PCMH”) concept of primary care (“PC”) with a medication-assisted treatment (“MAT”) model using prescription opioids such as methadone and buprenorphine. MAT is an Opioid Treatment Program (“OTP”) that uses FDA approved medications in combination with counseling and behavioral therapies to help individuals overcome opioid addiction.
The Disability Opportunity Fund (“DOF”) was asked to make a loan of $2,000,000 to Lotus Healthcare Group LLC (“LHG”) in order to open four new drug addiction and basic primary care service centers in Delaware, Maryland and West Virginia (the “Project”). The loan will help provide MAT treatment services to 2,900 patients by December 2022. These services are particularly needed in WV, where the overdose death rate by opioids has doubled between 2010 and 2017 and was three times the national rate in 2017. Nearly all states do not have sufficient treatment capacity to provide MAT to all patients with OUD.